Infectious Diseases in Children Current Issue
The following articles appeared in the print edition of Infectious Diseases in Children.
Table of Contents
- ‘We should have been prepared’: COVID-19 devastates vulnerable US Gerard Gallagher; Julia Ernst, MS; Ken Downey Jr.; Eamon N. Dreisbach
-
- FDA accepts Genentech’s drug applications for Xofluza in children
- FDA approves Eucrisa for atopic dermatitis in infants Ken Downey Jr.
- ACIP recommendations on dengue vaccination still pending Ken Downey Jr.
- Q&A: Is in-home child care safe during COVID-19 pandemic? Ken Downey Jr.
- Staying calm, vigilant can help mitigate COVID-19 effects on children’s mental health, experts say Joe Gramigna, MA
- Stewardship in the pediatrician’s office: Appropriate testing for group A strep Asif Noor, MD, FAAP; Ulka Kothari, MD
- Clinical manifestations of COVID-19 appear to be less severe in children Ken Downey Jr.
- Kids’ healthy diet scores improve by 27% Ken Downey Jr.
-
- Melatonin may help address sleep disorders in youths with autism Ken Downey Jr.
- Study supports AAP guidelines on screen exposure Ken Downey Jr.
- Acid suppressants increase risk for wheeze by age 3 in high-risk children Ken Downey Jr.
- CROI: Concentration of PrEP drug lower in pregnant girls and young women Ken Downey Jr.
- What is the US's single greatest weakness in regard to pandemic preparedness?
- 3-year-old boy presents to the ED with diffuse itchy rash Michele Khurana, MD; Marissa J. Perman, MD
- Always stick to the basics: History and physical James H. Brien, DO